Thomson Medical Group Limited
A50.SI : Singapore Exchange
0.050
-1.96%
Share Price in SGD. As of 26 Jul 17:04:43 SGT
All
Chart
Key stats
- 52-Week HighSGD 0.062
- 52-Week LowSGD 0.049
- Market CapSGD 1.3B
- Avg Volume2.3M
- P/E Ratio (TTM)Infinity
- Forward Dividend Yield0.8%
Share Price Performance
| A50.SI | Market
| |
|---|---|---|
| 1 Day | 0.00% | 0.24% |
| 5 Day | 2.04% | -0.31% |
| 1 Month | 0.00% | 2.49% |
| 6 Month | -3.85% | 9.02% |
| YTD | -18.03% | 6.08% |
| 1 Year | -12.28% | 6.50% |
| 5 Year | -10.71% | 9.82% |
Include dividend return
Market Analysis
Analyst Ratings
Maybank Research
27 Feb 2024
Buy
0.080
Valuation
Price to earnings (P/E) ratio
Current P/E
∞
∞
Historical Average P/E
NaN
NaN
Thomson Medical Group Limited's current P/E ratio of ∞x is inline with its historical average P/E ratio of NaNx.
Price to book (P/B) ratio
Current P/B
2.7
2.7
Historical Average P/B
2.8
2.8
Thomson Medical Group Limited's current P/B ratio of 2.7x is lower than its historical average P/B ratio of 2.8x.
Earnings
Earnings per share (EPS)
The latest earnings per share is $0.00, which is inline with the earnings per share of $0.00 in 2022.
Financials
Financial Statements
| 07 Feb 2024 | For period ending 31 Dec 2023 |
| 28 Aug 2023 | For period ending 30 Jun 2023 |
Annual Reports
| 22 Sep 2023 | For period ending 30 Jun 2023 |
News
Profile
Company Description
Listed on the Mainboard of the Singapore Exchange, Thomson Medical Group Limited (SGX: A50) is one of the leading listed healthcare players in the South-East Asian region with operations in Singapore and Malaysia.
Established in 1979, the Groupâs Thomson Medical Pte Ltd is one of the largest private provider of healthcare services for women and children in Singapore. It owns and operates the iconic Thomson Medical Centre and a network of specialist medical clinics and facilities providing outpatient women and children healthcare services and service offerings in diagnostic imaging, health screening, gynaecological oncology, dentistry, specialist dermatology, traditional Chinese medicine, musculoskeletal and sports medicine, and medical aesthetics.
The Group's operations in Malaysia under TMC Life Sciences Berhad is a multi-disciplinary healthcare company listed on Bursa Malaysia. It operates Thomson Hospital Kota Damansara, a tertiary hospital located in Kota Damansara, and the award-winning TMC Fertility Centre which is the industry leader in assisted reproduction in Malaysia. It also owns the proposed Thomson Iskandar Medical Hub, in Johor Bahru, Malaysia.
The Group also owns a prime 9.23 ha freehold waterfront land, strategically located in Johor Bahruâs City Centre, with a proposed long term plan to build an integrated healthcare city to meet the growing healthcare needs of the people in the region.